GuidelineBreast cancer (Tokyo, Japan)2024

Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines.

Masaya Hattori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.